康寧傑瑞製藥-B股票討論區

$康寧傑瑞製藥-B(09966.HK)$ 天天創歷史新低，香港股市崩潰……

$康寧傑瑞製藥-B(09966.HK)$ 敢敢往下跌📉，我在1塊錢這等你來👍💪💪💪

$恒生指數(800000.HK)$ plunge deepened unceasingly after midday. It once stumbled 620 pts or 3.9% to bottom at 15,245, hitting an over-14-month low; last at 15,320, down 545 pts or 3.4%, with a total turnover of $88.5 billion.
Pharmaceuticals were sold off. $榮昌生物(09995.HK)$ once collapsed 27.5% to $22.8; last at $24.9, down 21%.
$三葉草生物-B(02197.HK)$ nosedived 9.6% to $0.47, hitting record low. $維亞生物(01873.HK)$ ...

$康寧傑瑞製藥-B(09966.HK)$ 1塊錢這等你來

交銀國際認爲，康寧傑瑞製藥在NSCLC治療領域的競爭日趨激烈，而且公司此前推遲的KN046-301試驗數據讀出及在ESMO 2023的相關數據更新，並未增加該行對其在NSCLC治療成功開發的信心。

$康寧傑瑞製藥-B(09966.HK)$ If corning & Jerry's late-stage data can validate the early-stage data, it means that first-line treatment of NSCLC(MOS estimated at more than 25 months in phase II) can obtain MOS data much higher than K

$康寧傑瑞製藥-B(09966.HK)$$開拓藥業-B(09939.HK)$$信達生物(01801.HK)$ Today Hong Kong pharmaceutical and biotech stocks fell 2.36%, industry groups in Hong Kong or top 5, kill the biological medicine market valuation, capital is still wary of innovative drug, exploit medicine, corning jerry that is called a fall, but has strong industry leading cinda biology, growth of 4.16% in the pharmaceutical sector in the first, Market money still likes and likes a few big champions.

$康寧傑瑞製藥-B(09966.HK)$ Recist 41.9% and MRECist 60.5%, so 046 ORR may have a slight advantage, but the sample size is small